MEP1908A - Gabaksadol za liječenje depresije i drugih afektivnih poremećaja - Google Patents
Gabaksadol za liječenje depresije i drugih afektivnih poremećajaInfo
- Publication number
- MEP1908A MEP1908A MEP-19/08A MEP1908A MEP1908A ME P1908 A MEP1908 A ME P1908A ME P1908 A MEP1908 A ME P1908A ME P1908 A MEP1908 A ME P1908A
- Authority
- ME
- Montenegro
- Prior art keywords
- gaboxadol
- treating depression
- affective disorders
- pharmaceutical composition
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 | ||
PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP1908A true MEP1908A (xx) | 2010-02-10 |
Family
ID=58707228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-19/08A MEP1908A (xx) | 2003-06-25 | 2004-06-25 | Gabaksadol za liječenje depresije i drugih afektivnih poremećaja |
MEP-2008-19A ME00030B (me) | 2003-06-25 | 2004-06-25 | GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-19A ME00030B (me) | 2003-06-25 | 2004-06-25 | GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (xx) |
AR (1) | AR047550A1 (xx) |
CA (2) | CA2529805A1 (xx) |
CL (2) | CL2004001607A1 (xx) |
EA (1) | EA200600101A1 (xx) |
IS (1) | IS8138A (xx) |
ME (2) | MEP1908A (xx) |
NO (1) | NO20060229L (xx) |
RS (1) | RS20050911A (xx) |
TW (1) | TW200509918A (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113395962A (zh) | 2018-11-21 | 2021-09-14 | Certego治疗公司 | 加波沙朵用于降低自杀风险和快速缓解抑郁症 |
KR20230028244A (ko) | 2020-05-20 | 2023-02-28 | 썰테고 테라퓨틱스 아이엔씨. | 고리 중수소화 가복사돌 및 정신 장애의 치료를 위한 이의 용도 |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA200600101A1 (ru) | 2006-06-30 |
KR20060025192A (ko) | 2006-03-20 |
CA2529805A1 (en) | 2004-12-29 |
ME00030B (me) | 2010-06-10 |
CL2010000166A1 (es) | 2010-07-02 |
IS8138A (is) | 2005-11-21 |
RS20050911A (xx) | 2007-08-03 |
TW200509918A (en) | 2005-03-16 |
AR047550A1 (es) | 2006-01-25 |
CA2692334A1 (en) | 2004-12-29 |
NO20060229L (no) | 2006-01-16 |
CL2004001607A1 (es) | 2005-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172631A0 (en) | Gaboxadol for treating depression and other affective disorders | |
TW200740799A (en) | Alpha2C adrenoreceptor agonists | |
TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
CL2008003407A1 (es) | Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1. | |
MX2007010560A (es) | Roflumilast para el tratamiento de diabetes mellitus. | |
RS20050392A (xx) | Farmaceutski preparat sa beta-3- adrenoceptor-agonistom i reuptake-inhibitorom serotonina i/ili norepinefrina | |
MX2009010960A (es) | Compuestos heterociclicos y sus metodos de uso. | |
MA32776B1 (fr) | Inhibiteurs de l'akt et de la p70 s6 kinase | |
MX2012004548A (es) | Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central. | |
CL2008003231A1 (es) | Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura. | |
MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. | |
TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
TW200745133A (en) | New compounds II | |
MX2009013126A (es) | Nuevos compuestos 892. | |
WO2006128120A3 (en) | Novel lapachone compounds and methods of use thereof | |
UA90656C2 (ru) | Габоксадол для лечения депрессии | |
MEP1908A (xx) | Gabaksadol za liječenje depresije i drugih afektivnih poremećaja | |
WO2009158387A3 (en) | Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption | |
WO2007121883A3 (de) | 1,4:3,6-dianhydromannitol-derivate und deren verwendung | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
CL2009001113A1 (es) | Compuestos derivados de 4,5-diarilpirrol-2-carboxamida; procedimiento de preparacion de estos; composicion farmaceutica que los comprende; uso en el tratamiento y/o prevencion de trastornos psiquiatricos, dependencia a sustancias, entre otras. | |
MXPA06013945A (es) | Piperidinas sustituidas, novedosas, como moduladores de la neurotransmision de dopamina. | |
TW200504016A (en) | Inhibitors of monoamine uptake |